Acebutolol Hydrochloride
Overview
Acebutolol Hydrochloride is a cardioselective beta-adrenergic antagonist used primarily in the treatment of hypertension and cardiac arrhythmias. It works by blocking beta-1 adrenergic receptors in the heart, reducing heart rate and myocardial contractility.
API suppliers (7)
Suppliers of Acebutolol Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 6 of 7 suppliers.
4 of 7 hold a GMP certificate on record in the EU or UK registers
- CAMBREX PROFARMACO MILANO SRLItaly GMP on record
- ERREGIERRE SPAItaly GMP on record
- QUIMICA SINTETICA SASpain GMP on record
- SANOFI CHIMIEFrance
- LUSOCHIMICA SPAItaly GMP on record
- Genzyme CorporationUnited States
- SOLCHEM ITALIANA SPA
EU CEP holders (2)
Companies holding a valid EU Certificate of Suitability (CEP) for Acebutolol Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Acebutolol Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.